Law360, New York (January 21, 2014, 3:35 PM EST) -- The Sixth Circuit on Tuesday revived a wrongful death suit accusing Mylan Inc. of selling defective painkiller patches, finding that a Michigan law shielding drugmakers from liability doesn't apply to products that combine medicines and devices.
In a split decision, the appeals court disagreed with a district judge's conclusion that Mylan's fentanyl patches are akin to time-release capsules and therefore can't be viewed separately from the drug itself.
Under federal law, if the patch were considered to be an "article intended for use as a component" of fentanyl, then it could be seen as a drug. But the Sixth Circuit said...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!